← Scroll for more →
Financial Statements — CHKP
Balance Sheet
(in billions USD)| Metric | Q3 2025 |
|---|---|
| Cash & Equivalents | 0.62 |
| Accounts Receivable | 0.44 |
| Total Current Assets | 2.03 |
| Property, Plant & Equipment | 0.08 |
| Goodwill | 1.75 |
| Intangible Assets | 0.18 |
| Total Non-current Assets | 3.67 |
| Total Assets | 5.70 |
| Accounts Payable | 0.04 |
| Total Current Liabilities | 1.71 |
| Total Non-current Liabilities | 0.91 |
| Total Liabilities | 2.62 |
| Retained Earnings | 14.77 |
| Total Stockholder Equity | 3.08 |
← Scroll for more columns →
Income Statement
(in billions USD) (except per-share rows)| Metric | Q3 2025 |
|---|---|
| Total Revenue | 1.98 |
| Cost of Revenue | 0.26 |
| Gross Profit | 1.72 |
| Research & Development | 0.33 |
| Selling, General & Admin | 0.09 |
| Total Operating Expenses | 1.12 |
| Operating Income | 0.60 |
| Pretax Income | 0.68 |
| Tax Provision | (0.07) |
| Net Income | 0.75 |
| Basic EPS | 7.00 |
| Diluted EPS | 6.81 |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q3 2025 |
|---|---|
| Operating Cash Flow | 914.90 |
| Capital Expenditures | 19.40 |
| Free Cash Flow* | 895.50 |
| Investing Cash Flow | (145.10) |
| Financing Cash Flow | (656.10) |
← Scroll for more columns →
* Derived from reported values